SCHEMBL7328332

SCHEMBL7328332

CNC1CCc2c(cccc2NC(C)=O)C1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.55
DRD3 P35462 5/20 0.55
DRD4 P21917 3/20 0.55
MTNR1A P48039 3/20 0.52
MTNR1B P49286 3/20 0.52
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
SLC18A3 Q16572 1/20 0.47
CA1 P00915 4/20 0.47
CA2 P00918 4/20 0.47
ACHE P22303 4/20 0.47
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ADRA2A P08913 1/20 0.40
LMNA P02545 1/20 0.40
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7333108 0.99 DRD2 (0.53) DRD2DRD3DRD4MTNR1AMTNR1B
SCHEMBL7336034 0.85 DRD2 (0.57) DRD2DRD3DRD4MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL7334747 0.84 DRD2 (0.56) DRD2DRD3DRD4MTNR1AMTNR1B
SCHEMBL7326549 0.83 MTNR1A (0.62) MTNR1AMTNR1BNPC1RAB9ACA1
SCHEMBL7328237 0.83 DRD2 (0.65) DRD2DRD3DRD4MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL7334442 0.82 MTNR1A (0.46) DRD2DRD3DRD4MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL7329618 0.82 DRD2 (0.64) DRD2DRD3DRD4MTNR1AMTNR1B
SCHEMBL7336824 0.82 HTR6 (0.55) DRD2DRD3MTNR1AMTNR1BNPC1
SCHEMBL7328335 0.81 DRD2 (0.61) DRD2DRD3DRD4MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL7337748 0.81 MAOA (0.55) DRD2DRD3DRD4MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5196454-A METHOD OF TREATING DISORDERS OF THE DOPAMINERGIC SYSTEMS USING 2,5-DIAMINOTETRALINES BOEHRINGER INGELHEIM KG (DE) 1993-03-23 US disclosed
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP disclosed